Skip to main content

Incyte Corporation

Incyte Corporation
1801 Augustine Cut-Off
Wilmington, DE 19803
Phone: (855) 446-2983Website: Assistance Program:

Latest news

Drugs Associated with Incyte Corporation

Incyte Corporation manufactures, markets and/or distributes more than 4 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.

Brand/Generic Name Reviews Rating
Generic name: ruxolitinib
Drug class: multikinase inhibitors
31 reviews 7.4 / 10
Generic name: ruxolitinib
Drug class: topical antineoplastics
2 reviews 9.5 / 10
Generic name: pemigatinib
Drug class: multikinase inhibitors
1 review 1.0 / 10
Generic name: retifanlimab
Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).